A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir (vol 102, 001496, 2021)

dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniv Leeds
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2021-06-26T04:31:04Z
dc.date.accessioned2022-12-19T23:08:30Z
dc.date.available2021-06-26T04:31:04Z
dc.date.available2022-12-19T23:08:30Z
dc.date.created2021-06-26T04:31:04Z
dc.date.issued2021-01-01
dc.identifierJournal Of General Virology. London: Microbiology Soc, v. 102, n. 3, 1 p., 2021.
dc.identifier0022-1317
dc.identifierhttp://hdl.handle.net/11449/210739
dc.identifier10.1099/jgv.0.001582
dc.identifierWOS:000635958900045
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5391341
dc.languageeng
dc.publisherMicrobiology Soc
dc.relationJournal Of General Virology
dc.sourceWeb of Science
dc.titleA novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir (vol 102, 001496, 2021)
dc.typeOtros


Este ítem pertenece a la siguiente institución